142 related articles for article (PubMed ID: 9479568)
21. Lack of dominant-negative effects of a truncated gamma(c) on retroviral-mediated gene correction of immunodeficient mice.
Otsu M; Sugamura K; Candotti F
Blood; 2001 Mar; 97(6):1618-24. PubMed ID: 11238100
[TBL] [Abstract][Full Text] [Related]
22. X-linked SCID and other defects of cytokine pathways.
Uribe L; Weinberg KI
Semin Hematol; 1998 Oct; 35(4):299-309. PubMed ID: 9801259
[TBL] [Abstract][Full Text] [Related]
23. Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes.
Kondo M; Takeshita T; Higuchi M; Nakamura M; Sudo T; Nishikawa S; Sugamura K
Science; 1994 Mar; 263(5152):1453-4. PubMed ID: 8128231
[TBL] [Abstract][Full Text] [Related]
24. Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor gamma chain.
Ohbo K; Suda T; Hashiyama M; Mantani A; Ikebe M; Miyakawa K; Moriyama M; Nakamura M; Katsuki M; Takahashi K; Yamamura K; Sugamura K
Blood; 1996 Feb; 87(3):956-67. PubMed ID: 8562967
[TBL] [Abstract][Full Text] [Related]
25. In vivo competitive studies between normal and common gamma chain-defective bone marrow cells: implications for gene therapy.
Otsu M; Sugamura K; Candotti F
Hum Gene Ther; 2000 Sep; 11(14):2051-6. PubMed ID: 11020803
[TBL] [Abstract][Full Text] [Related]
26. Histologic characterization of the thymus in canine X-linked severe combined immunodeficiency.
Snyder PW; Kazacos EA; Felsburg PJ
Clin Immunol Immunopathol; 1993 Apr; 67(1):55-67. PubMed ID: 8443985
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans.
Noguchi M; Yi H; Rosenblatt HM; Filipovich AH; Adelstein S; Modi WS; McBride OW; Leonard WJ
Cell; 1993 Apr; 73(1):147-57. PubMed ID: 8462096
[TBL] [Abstract][Full Text] [Related]
28. Acute monocytic leukemia in a dog with X-linked severe combined immunodeficiency.
Felsburg PJ; Somberg RL; Krakowka GS
Clin Diagn Lab Immunol; 1994 Jul; 1(4):379-84. PubMed ID: 8556472
[TBL] [Abstract][Full Text] [Related]
29. Domestic animal models of severe combined immunodeficiency: canine X-linked severe combined immunodeficiency and severe combined immunodeficiency in horses.
Felsburg PJ; Somberg RL; Perryman LE
Immunodefic Rev; 1992; 3(4):277-303. PubMed ID: 1449787
[TBL] [Abstract][Full Text] [Related]
30. Canine lymphocyte expression of retrovirally transferred human common gamma chain.
Whitwam T; Haskins ME; Henthorn PS; Bodine DM; Puck JM
Ann N Y Acad Sci; 1999 Apr; 872():387-90. PubMed ID: 10372141
[No Abstract] [Full Text] [Related]
31. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy.
Hacein-Bey-Abina S; Le Deist F; Carlier F; Bouneaud C; Hue C; De Villartay JP; Thrasher AJ; Wulffraat N; Sorensen R; Dupuis-Girod S; Fischer A; Davies EG; Kuis W; Leiva L; Cavazzana-Calvo M
N Engl J Med; 2002 Apr; 346(16):1185-93. PubMed ID: 11961146
[TBL] [Abstract][Full Text] [Related]
32. Mutations in the gene for the common gamma chain (gammac) in X-linked severe combined immunodeficiency.
Fugmann SD; Müller S; Friedrich W; Bartram CR; Schwarz K
Hum Genet; 1998 Dec; 103(6):730-1. PubMed ID: 9921912
[TBL] [Abstract][Full Text] [Related]
33. Function of the interleukin-2 (IL-2) receptor gamma-chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL-15.
Matthews DJ; Clark PA; Herbert J; Morgan G; Armitage RJ; Kinnon C; Minty A; Grabstein KH; Caput D; Ferrara P
Blood; 1995 Jan; 85(1):38-42. PubMed ID: 7803808
[TBL] [Abstract][Full Text] [Related]
34. X-linked severe combined immunodeficiency: from molecular cause to gene therapy within seven years.
Leonard WJ
Mol Med Today; 2000 Oct; 6(10):403-7. PubMed ID: 11006530
[TBL] [Abstract][Full Text] [Related]
35. Keratinocyte antiviral response to Poly(dA:dT) stimulation and papillomavirus infection in a canine model of X-linked severe combined immunodeficiency.
Luff JA; Yuan H; Kennedy D; Schlegel R; Felsburg P; Moore PF
PLoS One; 2014; 9(7):e102033. PubMed ID: 25025687
[TBL] [Abstract][Full Text] [Related]
36. Intrinsic defects of B cell function in X-linked severe combined immunodeficiency.
White H; Thrasher A; Veys P; Kinnon C; Gaspar HB
Eur J Immunol; 2000 Mar; 30(3):732-7. PubMed ID: 10741387
[TBL] [Abstract][Full Text] [Related]
37. Stable and functional lymphoid reconstitution of common cytokine receptor gamma chain deficient mice by retroviral-mediated gene transfer.
Soudais C; Shiho T; Sharara LI; Guy-Grand D; Taniguchi T; Fischer A; Di Santo JP
Blood; 2000 May; 95(10):3071-7. PubMed ID: 10807771
[TBL] [Abstract][Full Text] [Related]
38. Shared gamma(c) subunit within the human interleukin-7 receptor complex. A molecular basis for the pathogenesis of X-linked severe combined immunodeficiency.
Lai SY; Molden J; Goldsmith MA
J Clin Invest; 1997 Jan; 99(2):169-77. PubMed ID: 9005984
[TBL] [Abstract][Full Text] [Related]
39. X chromosome inactivation patterns in haematopoietic cells of female carriers of X-linked severe combined immunodeficiency determined by methylation analysis at the hypervariable DXS255 locus.
Hendriks RW; Kraakman ME; Schuurman RK
Clin Genet; 1992 Sep; 42(3):114-21. PubMed ID: 1395081
[TBL] [Abstract][Full Text] [Related]
40. Gnotobiotics and immunopathology: the use of the gnotobiotic environment to study acquired and inherited immunodeficiency diseases.
Krakowka S; Felsburg P
Vet Immunol Immunopathol; 2005 Oct; 108(1-2):165-75. PubMed ID: 16112740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
